Aterian (NASDAQ:ATER) Releases Earnings Results, Misses Estimates By $0.39 EPS

Aterian (NASDAQ:ATER) issued its earnings results on Saturday. The company reported ($0.97) earnings per share for the quarter, missing the consensus estimate of ($0.58) by ($0.39), FiscalAI reports. The firm had revenue of $15.13 million during the quarter, compared to the consensus estimate of $18.38 million. Aterian had a negative return on equity of 47.45% and a negative net margin of 15.73%.

Aterian Stock Up 1.7%

ATER opened at $0.60 on Monday. The firm has a 50-day simple moving average of $0.65 and a two-hundred day simple moving average of $0.80. Aterian has a 52 week low of $0.52 and a 52 week high of $2.56. The company has a market capitalization of $6.02 million, a PE ratio of -0.37 and a beta of 0.02.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aterian in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Aterian currently has an average rating of “Reduce”.

Hedge Funds Weigh In On Aterian

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. XTX Topco Ltd purchased a new position in Aterian during the 2nd quarter valued at approximately $55,000. Susquehanna International Group LLP grew its holdings in shares of Aterian by 310.2% in the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after purchasing an additional 30,637 shares in the last quarter. Citadel Advisors LLC increased its position in Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after purchasing an additional 22,865 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after purchasing an additional 9,026 shares in the last quarter. 7.02% of the stock is owned by institutional investors.

About Aterian

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.